Abstract
Having observed that multiple neutralization epitopes of human T-cell-leukemia-virus-type-I (HTLV-I) envelope gp46 clustered in a region between amino acids 187 and 199, we speculated that a region of HTLV-II gp46 corresponding to the HTLV-I-neutralization region may contain HTLV-II-specific neutralization epitopes. To test this, we immunized a NZW rabbit and BALB/c mice with a synthetic peptide containing the HTLV-II gp46 amino acids 182 to 199 (pep182-199) conjugated to OVA. The serum from the rabbit reacted to the HTLV-II gp46 and neutralized HTLV-II-mediated syncytium formation. One monoclonal antibody (MAb), M2E186N1, generated from the BALB/c mice, stained specifically the surface of HTLV-II-positive cells and reacted with HTLV-II gp46 by Western blot. This MAb was of the IgA isotype and inhibited HTLV-II- but not HTLV-I-mediated syncytium formation at a final antibody concentration of 200 micrograms/ml; it also neutralized an HTLV-II-VSV pseudotype virus specifically. Epitope mapping by ELISA using overlapping synthetic peptides indicated that the neutralization epitope recognized by the M2E186N1 MAb was located between HTLV-II gp46 amino acids 186 and 192, corresponding to the sequence Leu-Gln-His-Val-Ile-Leu-Gln-Pro. T...Continue Reading
References
Oct 1, 1992·Journal of Virology·T J PalkerR A Weiss
Apr 1, 1992·Journal of Virology·W W HallR C Gallo
Jan 1, 1992·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·K HayashiK Miyamoto
Jul 1, 1992·The Journal of Infectious Diseases·E M MaloneyW A Blattner
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·E DeFreitasH Koprowski
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P HoralA Vahlne
Jun 16, 1990·Lancet·J B PageM A Fletcher
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M D LairmoreJ E Kaplan
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K ShimotohnoT Sugimura
Apr 28, 1989·Science·H LeeI S Chen
May 3, 1986·Lancet·M OsameM Tara
Dec 19, 1987·Lancet·C BartholomewF Cleghorn
Jan 1, 1985·Current Topics in Microbiology and Immunology·R A WeissH Hoshino
Dec 15, 1986·FEBS Letters·H ShimaM Miwa
Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·Y HinumaI Miyoshi
Dec 1, 1993·The Journal of Infectious Diseases·H HoshinoR Yanagihara
Jul 9, 1993·International Journal of Cancer. Journal International Du Cancer·N OharaT Akagi
Mar 1, 1993·Journal of Virology·D K DubeJ B Glaser
Citations
Jan 1, 1996·Archives of Virology·N KariyaT Akagi
Jan 29, 1999·Research in Virology·D X FuH Hoshino
Oct 28, 1998·Hybridoma·E MiyagawaS Ito
Jun 21, 2013·Journal of Virology·Priya KannianPatrick L Green
Oct 12, 2005·Human Immunology·G S PontesA C R Vallinoto
Jun 21, 2005·Virology·Marie-Eve ParéBenoit Barbeau
Sep 10, 1999·Reviews in Medical Virology·M Van BrusselA M Vandamme
Apr 16, 2003·Preparative Biochemistry & Biotechnology·Milenen Hernández MarinCarlos Silva León
Aug 8, 1998·Journal of Virology·A R RosenbergM C Dokhélar
Jan 29, 2021·Journal of Clinical Microbiology·Ueriton Dias de OliveiraNilson Ivo Tonin Zanchin
Aug 1, 1997·Journal of Virology·K G HadlockS K Foung